These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 4606535)
1. Evaluation of three anorexiants. Clortermine hydrochloride (voranil), fenfluramine hydrochloride (pondimin), and mazindol (sanorex). Dykes MH JAMA; 1974 Oct; 230(2):270-2. PubMed ID: 4606535 [No Abstract] [Full Text] [Related]
2. Comparison of a new anorectic agent AN 448 with fenfluramine in the treatment of refractory obesity. Goldrick RB; Nestel PJ; Havenstein N Med J Aust; 1974 Jun; 1(22):882-5. PubMed ID: 4604249 [No Abstract] [Full Text] [Related]
3. Fenfluramine in the treatment of obesity. Stunkard A; Rickels K; Hesbacher P Lancet; 1973 Mar; 1(7802):503-5. PubMed ID: 4119946 [No Abstract] [Full Text] [Related]
4. A comparative trial of different regimens of fenfluramine and phentermine in obesity. Steel JM; Munro JF; Duncan LJ Practitioner; 1973 Aug; 211(262):232-6. PubMed ID: 4580610 [No Abstract] [Full Text] [Related]
5. Toxic and therapeutic effects of EMTP in obesity. Hollingsworth DR; Amatruda TT Clin Pharmacol Ther; 1969; 10(4):540-2. PubMed ID: 4893585 [No Abstract] [Full Text] [Related]
6. [Experience with the appetite depressant, fenfluramine hydrochloride, in adiposity]. Liebermeister H; Probst G; Jahnke K Med Klin; 1969; 64(26):1201-7. PubMed ID: 5807324 [No Abstract] [Full Text] [Related]
7. Obesity-depression: clinical evaluation with a new anorexigenic agent. Kornhaber A Psychosomatics; 1973; 14(3):162-7. PubMed ID: 4604838 [No Abstract] [Full Text] [Related]
8. Withdrawal depression in obese patients after fenfluramine treatment. Steel JM; Briggs M Br Med J; 1972 Jul; 3(5817):26-7. PubMed ID: 5039550 [TBL] [Abstract][Full Text] [Related]
9. Double-blind clinical evaluation of mazindol, dextroamphetamine, and placebo in treatment of exogenous obesity. Defelice EA; Chaykin LB; Cohen A Curr Ther Res Clin Exp; 1973 Jul; 15(7):358-66. PubMed ID: 4198296 [No Abstract] [Full Text] [Related]
10. A collaborative investigation of fenfluramine. Anorexigenic with sedative properties. Elliott BW Curr Ther Res Clin Exp; 1970 Aug; 12(8):502-15. PubMed ID: 4988837 [No Abstract] [Full Text] [Related]
11. To the Editor: Fenfluramine (Poderax) for obesity. Jackson WP S Afr Med J; 1969 Sep; 43(39):1207. PubMed ID: 5353789 [No Abstract] [Full Text] [Related]
12. Hypotensive effect of fenfluramine in the treatment of obesity. Practitioner; 1971 Jul; 207(237):101-5. PubMed ID: 5557039 [No Abstract] [Full Text] [Related]
13. Double-blind trial of anorectic agents. Sproule BC Med J Aust; 1969 Feb; 1(8):394-5. PubMed ID: 4889477 [No Abstract] [Full Text] [Related]
14. Fenfluramine (Ponderax) in the treatment of obese psychiatric out-patients. Gaind R Br J Psychiatry; 1969 Aug; 115(525):963-4. PubMed ID: 4895336 [No Abstract] [Full Text] [Related]
15. Two new appetite suppressants. Med Lett Drugs Ther; 1974 Jun; 16(13):54. PubMed ID: 4842602 [No Abstract] [Full Text] [Related]
16. A comparative trial of fenfluramine and diethylpropion inbesity. Silverstone JT; Cooper RM; Begg RR Br J Clin Pract; 1970 Oct; 24(10):423-5. PubMed ID: 4923926 [No Abstract] [Full Text] [Related]
17. A comparative trial of fenfluramine and diethylpropion in obese, hypertensive patients. Follows OJ Br J Clin Pract; 1971 May; 25(5):236-8. PubMed ID: 4931755 [No Abstract] [Full Text] [Related]
18. Fenfluramine dependence. Harding T Br Med J; 1971 Jul; 3(5769):305. PubMed ID: 5557547 [No Abstract] [Full Text] [Related]
19. A new anorexiant. Clinical evaluation. Smith DE Rocky Mt Med J; 1974 Jan; 71(1):41-4. PubMed ID: 4131377 [No Abstract] [Full Text] [Related]